Kiora Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary

Kiora Pharmaceuticals

09/08/2024 15:42

* Kiora Pharmaceuticals Inc  KPRX.OQ  reported a quarterly
adjusted loss of 53 cents​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of $-7.11.  The mean expectation of
three analysts for the quarter was for a loss of 86 cents per
share. Wall Street expected results to range from -95 cents
to -81 cents per share.
    * Revenue was $20.00 million​; analysts expected zero. 
    * Kiora Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 53 cents​.
    * The company reported a quarterly loss of $2.22 million.
    * Kiora Pharmaceuticals Inc shares had fallen by 22.4% this
quarter and lost 30.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 10%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $27.00 
This summary was machine generated from LSEG data August 9 at
02:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.86          -0.53          Beat
 Mar. 31 2024      -0.59          3.42           Beat
 Dec. 31 2023      -3.77          -4.23          Missed
 Sep. 30 2023      -3.18          -8.01          Missed